Development and validation of sandwich ELISA microarrays with minimal assay interference.

Abstract

Sandwich enzyme-linked immunosorbent assay (ELISA) microarrays are emerging as a strong candidate platform for multiplex biomarker analysis because of the ELISA's ability to quantitatively measure rare proteins in complex biological fluids. Advantages of this platform are high-throughput potential, assay sensitivity and stringency, and the similarity to the standard ELISA test, which facilitates assay transfer from a research setting to a clinical laboratory. However, a major concern with the multiplexing of ELISAs is maintaining high assay specificity. In this study, we systematically determine the amount of assay interference and noise contributed by individual components of a multiplexed 24-assay system. We find that nonspecific reagent cross-reactivity problems are relatively rare. We did identify the presence of contaminant antigens in a "purified antigen". We tested the validated ELISA microarray chip using paired serum samples that had been collected from four women at a 6-month interval. This analysis demonstrated that protein levels typically vary much more between individuals than within an individual over time, a result which suggests that longitudinal studies may be useful in controlling for biomarker variability across a population. Overall, this research demonstrates the importance of a stringent screening protocol and the value of optimizing the antibody and antigen concentrations when designing chips for ELISA microarrays.

Biomarkers

The following biomarkers make reference to this publication:

Protocols

One protocol is associated with this publication:

EDRN PI Authors
Medline Author List
  • Brown M
  • Crowley SA
  • Gonzalez RM
  • Hayes DF
  • Omenn GS
  • Seurynck-Servoss SL
  • Zangar RC
PubMed ID
18422355
Appears In
J Proteome Res, 2008 Jun, volume 7 (issue 6)